0
"5.2.8.2	
Summary of evidence and recommendations for performing prostate biopsy  
(in line with the EAU Urological Infections Guidelines Panel)"
"Recommendations
Strength rating"
Any risk group staging
"Use pre-biopsy MRI for local staging information.
Weak"
"Treatment should not be changed based on PSMA PET/CT findings, in view of current 
Strong
available data."
Low-risk localised disease
"Do not use additional imaging for staging purposes. 
Strong"
Intermediate-risk disease
"Weak
In ISUP grade 3, include at least cross-sectional abdominopelvic imaging and a bone-scan 
for metastatic screening."
High-risk localised disease/locally-advanced disease
"Perform metastatic screening including at least cross-sectional abdominopelvic imaging 
Strong
and a bone-scan."
"When using PSMA-PET or whole body MRI to increase sensitivity, be aware of the lack of 
Strong
outcome data of subsequent treatment changes."
